← FDA Drug Approvals (Drugs@FDA)
SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2016-01-21
Drug application
- FDA Application #
ANDA205942- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
- Generic name
- Saxagliptin
- Active ingredients
- SAXAGLIPTIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AMNEAL PHARMS
- First approval
- 2016-01-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown